NR 511 Week 6 Case Study Discussion - Part 2

  • NR 511 Week 6 Case Study Discussion - Part 2
  • $20.00


Term July/August 2018
Institution Chamberlain
Contributor James

NR 511 Week 6 Case Study Discussion

Part Two

 

Now, assume that you sent your patient for labs and she returns the following day, as instructed, to review the results.

CBC with differential

WBC

8.6 x10E3/uL

RBC

4.44 x 10E6/uL

Hemoglobin

14.0 g/dL

Hematocrit

41.2%

MCV

93fL

MCH

31.5 pg

MCHC

34.0 g/dL

RDW

13%

Platelet

241 x 10E3/uL

Neutrophils %

67%

Lymphocytes %

22%

Monocytes %

8%

Eosinophils %

3%

Basophils %

0%

Absolute Neutrophils

5.7 x 10E3/uL

Absolute Lymphocytes

1.9 x 10E3/uL

Absolute Monocytes

0.7 x 10E3/uL

Eosinophils Absolute

0.3  x 10E3/uL

Basophile Absolute

0.0  x 10E3/uL

Immature Grans %

0%

Absolute Immature Grans

0.0 x 10E3/uL

TSH with Reflex to FT4

TSH

6.770 uIU/mL

FT4

0.62 ng/dL

 

PHQ-9 Depression Score=10 (previous was 5 at last visit 6 months ago)

  1. What is your primary diagnosis for this patient as the cause for the CC of fatigue? (support your decision for your diagnosis with pertinent positives and negatives from the case) 
  2. Identify the corresponding ICD-10 code. 
  3. Provide a treatment plan for this patient's primary diagnosis which includes: 
    1. Medication* 
    2. Any additional testing necessary for this particular diagnosis*
    3. Patient education* 
    4. Referral
  4. Provide an active problem list for this patient based on the information given in the case. 
  5. Are there any changes that you would make to the patient's overall plan at this time? Must provide an evidence-based medicine (EBM) argument to support any treatments or testing decisions. 
  6. Provide an appropriate follow-up plan (include any additional testing that you feel is necessary and include an EBM argument). 

 

If part of the plan does not warrant an action, you must explain why. ALL medication and testing decisions (or decisions not to treat with medication or additional testing) MUST be supported with an EBM argument. Over-the-counter (OTC) and RXs must be written in full as if handing a script to the patient in the office.

 

 

Instituition / Term
Term July/August 2018
Institution Chamberlain
Contributor James
 

Related Products

xNR 511 Test Bank Answers

$99.00